Abstract
Immunotherapy of cancer with checkpoint inhibitors has been associated with a spectrum of autoimmune and systemic inflammatory reactions known as immune-related adverse events (irAEs). Rheumatic irAEs are infrequently reported and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have